Weltelmi 80mg Tablet

Weltelmi 80mg is well-tolerated, with a favorable safety profile, and is administered orally once daily, providing sustained blood pressure control. Common adverse effects may include dizziness, headache, and fatigue, while serious side effects are rare but may involve renal impairment or hyperkalemia, necessitating periodic monitoring of renal function and electrolytes during therapy.

It is contraindicated in patients with hypersensitivity to Telmisartan or its components and should be used cautiously in patients with severe hepatic impairment or bilateral renal artery stenosis. Weltelmi 80mg should not be co-administered with aliskiren in diabetic patients or those with renal impairment. Patient adherence to prescribed dosage and regular follow-up are essential for optimal therapeutic outcomes.